DISTINCTION. The Department of Rheumatology and Inflammation Research at the Institute of Medicine, University of Gothenburg, has been designated as a EULAR Center of Excellence in Rheumatology 2022–2027. This is the third time the Department has received the award, held by only two universities in Sweden. The title is awarded by the European Alliance of Associations for Rheumatology, EULAR to rheumatology units that combine high-quality research with clinical work and…
Consistently high-quality technology improves research on rheumatoid arthritis
GRANTS. Treatment options for rheumatoid arthritis have come a long way in recent years, but 30 to 40 percent of people with the disease do not respond to modern treatments. A grant of SEK 3.4 million from the IngaBritt and Arne Lundberg Research Foundation is now supporting research aimed at developing more precise pharmaceuticals. The money will be used for new technologies to prepare tissue samples that can be used…
New insight into receptors on the surface of B cells – relevant for cancer treatment
NEW STUDY. A study by researchers in the Department of Rheumatology and Inflammation identifies a mechanism in the signal system that activates B cells. The findings could enable new ways of treating cancer diseases caused by B cells becoming malignant, such as certain forms of lymphoma. This research is fundamental and increases the understanding of the cascade of signals that lead to activation of a B cell when it encounters…